Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries

被引:757
作者
Gaziano, Thomas A. [1 ,2 ,3 ]
Bitton, Asaf [4 ,5 ]
Anand, Shuchi
Abrahams-Gessel, Shafika
Murphy, Adrianna [6 ]
机构
[1] Harvard Univ, Sch Med, Div Cardiovasc Med, Brigham & Womens Hosp, Cambridge, MA 02138 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA
[3] Univ Cape Town, ZA-7700 Rondebosch, South Africa
[4] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Cambridge, MA 02138 USA
关键词
ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; DEVELOPING-WORLD; ARTERY-DISEASE; GLOBAL BURDEN; RISK-FACTORS; NONCOMMUNICABLE DISEASES; SECONDARY PREVENTION; METABOLIC SYNDROME; SUBGROUP ANALYSIS;
D O I
10.1016/j.cpcardiol.2009.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary heart disease (CHD) is the single largest cause of death in the developed countries and is one of the leading causes of disease burden in developing countries. In 2001, there were 7.3 million deaths due to CHD worldwide. Three-fourths of global deaths due to CHD occurred in the low- and middle-income countries. The rapid rise in CHD burden in most of the low- and middle-income countries is due to socioeconomic changes, increase in lifespan, and acquisition of lifestyle-related risk factors. The CHD death rate, however, varies dramatically across the developing countries. The varying incidence, prevalence, and mortality rates reflect the different levels of risk factors, other competing causes of death, availability of resources to combat cardiovascular disease, and the stage of epidemiologic transition that each country or region finds itself. The economic burden of CHD is equally large but solutions exist to manage this growing burden. (Curr Probl Cardiol 2010;35:72-115.)
引用
收藏
页码:72 / 115
页数:44
相关论文
共 122 条
[1]   Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease [J].
Ahmad, N ;
Bhopal, R .
HEART, 2005, 91 (06) :719-725
[2]  
Ajay VS, 2002, NATL CARDIOVASCULAR
[3]   Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT [J].
Akkerhuis, KM ;
Deckers, JW ;
Boersma, E ;
Harrington, RA ;
Stepinska, J ;
Mahaffey, KW ;
Wilcox, RG ;
Lincoff, AM ;
Keltai, M ;
Topol, EJ ;
Califf, RM ;
Simoons, ML .
EUROPEAN HEART JOURNAL, 2000, 21 (05) :371-381
[4]  
Al-Nozha MM, 2004, SAUDI MED J, V25, P1165
[5]  
[Anonymous], REP GLOB TOB EP 2008
[6]  
[Anonymous], FACT SHEET: Diabetes in India
[7]  
[Anonymous], 2003, HEART DIS STROK STAT
[8]  
[Anonymous], 2012, World Development Indicators
[9]  
[Anonymous], 2013, WORLD HLTH REPORT 20
[10]  
[Anonymous], 2002, World Development Indicators